YOLFTbeta
18

Chong Kun Dang Pharmaceutical

185750 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

61,300.00KRW-3300.00 (-5.11%)

Price History

Full chart

Market Stats

Previous Close64,600.00
Open63,000.00
Day Range61,000.00 – 63,400.00
52-Week Range63,000.00 – 98,100.00
Volume23.46K
Market Cap856.44B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.77%
Beta0.25
50-Day Avg67,206.00
200-Day Avg78,661.00

About

Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Young-Joo Kim
  • Employees2.17K
  • HeadquartersChong Kun Dang Building, Seoul, South Korea, Korea
  • Websitehttps://www.ckdpharm.com

Leadership

  • Mr. Young-Joo KimPresident, CEO & Chairman

Financials

Income Statement

Currency: KRW2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue831.99B884.36B956.22B1.08T1.30T1.34T1.49T1.67T1.59T1.69T
Growth (%)-+6.30%+8.13%+12.88%+20.72%+3.11%+10.78%+12.17%-4.97%+6.68%
Cost of Revenue497.10B524.71B575.82B675.06B813.87B847.74B945.71B1.01T1.05T1.17T
Gross Profit334.89B359.66B380.40B404.28B489.14B495.82B542.64B662.20B532.61B526.38B
Gross Margin40.25%40.67%39.78%37.46%37.54%36.90%36.46%39.67%33.57%31.10%
Operating Expense273.64B281.89B304.66B329.70B365.20B401.06B432.73B415.60B433.15B445.81B
Operating Income61.25B77.76B75.74B74.58B123.94B94.76B109.91B246.60B99.46B80.57B
Operating Margin7.36%8.79%7.92%6.91%9.51%7.05%7.38%14.77%6.27%4.76%
EBITDA-100.09B92.27B98.02B149.50B112.11B137.61B287.90B150.10B133.15B
EBITDA Margin-11.32%9.65%9.08%11.47%8.34%9.25%17.25%9.46%7.87%
Net Income40.95B53.81B42.40B53.88B91.63B42.72B80.95B212.52B109.07B77.51B
Net Income Margin4.92%6.08%4.43%4.99%7.03%3.18%5.44%12.73%6.88%4.58%
R&D67.18B65.05B77.03B98.62B146.66B163.28B176.32B140.23B143.91B154.10B
R&D as % of Total Revenue8.07%7.36%8.06%9.14%11.26%12.15%11.85%8.40%9.07%9.11%
Interest Expense002.71B3.15B3.87B4.03B6.85B9.27B8.32B6.70B
Interest Expense % of Total Revenue0.00%0.00%0.28%0.29%0.30%0.30%0.46%0.56%0.52%0.40%

Balance Sheet

Currency: KRW2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets641.70B677.21B711.49B801.35B946.33B1.05T1.12T1.40T1.46T1.80T
Total Liabilities287.45B273.91B280.60B326.40B394.74B480.89B503.59B586.79B562.39B793.94B
Total Equity354.25B401.71B428.73B473.52B551.43B566.01B622.39B815.69B893.97B1.00T
Cash21.72B45.47B45.95B76.92B123.66B131.81B117.42B219.65B228.47B216.24B
Net Debt-56.99B58.52B34.12B7.32B101.77B116.63B--141.79B

Cash Flow

Currency: KRW2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow57.79B81.67B42.63B77.29B104.32B12.90B67.73B318.16B64.29B67.36B
Investing Cash Flow-43.40B-23.88B-30.33B-39.73B-63.92B-90.81B-65.38B---
Financing Cash Flow-5.64B-34.73B-11.74B-6.59B7.07B85.14B-16.34B---
Capital Expenditure39.44B19.79B21.92B21.84B32.64B48.24B44.90B68.81B66.10B179.13B
Free Cash Flow-60.35B17.99B52.43B67.51B-38.94B14.67B249.35B-1.81B-111.77B
Dividends Paid5.64B8.46B8.46B8.84B9.28B10.81B11.24B11.61B13.33B13.82B
FCF to OCF-73.89%42.20%67.83%64.71%-301.77%21.66%78.37%-2.82%-165.94%
Dividend Paid to FCF-14.02%47.05%16.86%13.74%-27.76%76.61%4.66%-735.21%-12.37%

Earnings

Report DateMar 31, 2014Aug 14, 2014Oct 31, 2014Feb 6, 2015May 8, 2015Aug 13, 2015Nov 4, 2015Feb 5, 2016Apr 29, 2016Jul 28, 2016Nov 14, 2016Mar 31, 2017Apr 24, 2017Jul 28, 2017Nov 2, 2017Feb 1, 2018Apr 27, 2018Jul 26, 2018Nov 1, 2018Jan 31, 2019Apr 26, 2019Jul 26, 2019Nov 1, 2019Jan 31, 2020Apr 29, 2020Jul 30, 2020Oct 30, 2020Mar 18, 2021Apr 30, 2021Aug 17, 2021Oct 29, 2021Feb 10, 2022Apr 29, 2022Aug 16, 2022Oct 28, 2022Feb 3, 2023Apr 28, 2023Jul 28, 2023Oct 26, 2023Feb 5, 2024Apr 26, 2024Jul 26, 2024Oct 25, 2024May 15, 2025Aug 12, 2025Nov 12, 2025Dec 31, 2025Apr 28, 2026
EPS Estimate-824.40---881.24-774.00566.67801.91609.16830.48954.991011.361290.281292.331341.481193.271475.321498.811048.791012.541251.161113.441336.391281.621622.79912.191684.042027.281938.641113.971550.101811.242039.371179.921597.072066.872297.451179.181721.881896.911487.891715.54----
EPS Actual780.29823.04732.64289.16484.78-1901.24665.13548.00562.86740.001072.79947.581102.951082.091598.191338.95260.321173.701252.611227.21955.101113.831277.101394.101499.322316.552929.711259.091203.631922.00172.34137.141413.331882.862336.191023.002947.003523.003755.006983.192013.004208.001726.00894.001446.871525.692015.33973.02
Surprise--0.17%----315.75%--29.20%-0.67%-7.72%76.11%14.10%15.49%6.99%23.86%3.61%-80.59%-1.64%-15.10%-18.12%-8.93%10.00%2.07%25.21%12.19%80.75%80.54%38.03%-28.53%-5.19%-91.11%-87.69%-8.82%3.95%14.55%-13.30%84.53%70.45%63.44%492.21%16.91%121.83%16.00%-47.89%----
Timing-After-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hours-Pre-marketPre-market---After-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market

Key Statistics & Ratios

Market Cap856.44B
Enterprise Value963.27B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.48
Price / Book0.84
Revenue (TTM)1.78T
Gross Profit (TTM)531.06B
EBITDA122.95B
Profit Margin4.46%
Operating Margin3.89%
Return on Equity8.23%
Return on Assets2.86%
Shares Outstanding13.18M
Shares Float7.63M
Beta0.25
Dividend Yield0.77%
Dividend Rate500.00
Payout Ratio11.08%

Dividends

20251×
500.00Dec 29, 2025
20241×
1100.00Dec 27, 2024
20231×
1047.62Dec 27, 2023
20221×
907.03Dec 28, 2022
20211×
863.84Dec 29, 2021
20201×
783.53Dec 29, 2020
20191×
671.59Dec 27, 2019
20181×
671.59Dec 27, 2018
20171×
609.16Dec 27, 2017
20161×
609.16Dec 28, 2016
20151×
406.10Dec 29, 2015
20141×
541.47Dec 29, 2014
20131×
203.05Dec 27, 2013

Stock Splits

  • Dec 27, 20241.05:1
  • Dec 27, 20231.05:1
  • Dec 28, 20221.05:1
  • Dec 29, 20211.05:1
  • Dec 29, 20201.05:1
  • Dec 27, 20191.05:1
  • Dec 27, 20181.05:1
  • Feb 5, 20181.05:1